Article

Deacetylation of catalytic lysine in CDK1 is essential for Cyclin-B binding and cell cycle

medRxiv · 2018 · Deota, S.; Rathnachalam, S.; Namrata, K.; Boob, M.; Fulzele, A.; S, R.; Ganguli, S.; Balaji, C.; Kaypee, S.; Vishwakarma, K. K.; Kundu, T. K.; Bhandari, R.; Gozalez de Peredo, A.; Mishra, M.; Venkatramani, R.; Kolthur-Seetharam, U.

Key facts

Title Deacetylation of catalytic lysine in CDK1 is essential for Cyclin-B binding and cell cycle
First author Deota, S.; Rathnachalam, S.; Namrata, K.; Boob, M.; Fulzele, A.; S, R.; Ganguli, S.; Balaji, C.; Kaypee, S.; Vishwakarma, K. K.; Kundu, T. K.; Bhandari, R.; Gozalez de Peredo, A.; Mishra, M.; Venkatramani, R.; Kolthur-Seetharam, U.
Journal medRxiv
Published Sep 20, 2018
DOI 10.1101/420000
Devices mentioned DEN000008, K022086, K103302, K864267, K922885, K925155
Product codes mentioned CIT, DPM, NDS, JCI, KIT, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature